Endo and Allergan settle major opiod case for $15 million

Endo and Allergan have reached an agreement to pay $15 million to avoid going to trial in a case by two Ohio counties accusing drug manufacturers of feeding the U.S. opioid epidemic.

Endo has agreed to pay Cuyahoga and Summit counties $10 million while Allergan has agreed to pay $5 million to resolve claims involving its branded opioids. Endo also agreed to provide up to $1 million worth of its drug products for free.

Other companies still set to face trial on October 21 include drugmakers Purdue Pharma, Teva and Johnson & Johnson.

Both companies deny wrongdoing in the opioid epidemic.

Read the Reuters report